Risk-Based Quality Assessment Growing Among ANDA Chemistry Reviews
The Office of Generic Drugs implemented risk-based quality assessment for some ANDA chemistry reviews in 2013 and found it helped speed up the process and enabled reviewers to better handle the submission volume.
You may also be interested in...
Experts say one idea may be to borrow some new drug staff to help relieve the pressure; FDA says it will use all available resources.
FDA could help create several international coalitions to carry out its new globalization plan, which could allow for issue-specific groups focused on individual pharmaceutical sectors.
Vaccines and Related Biological Products Advisory Committee also said that more data is needed to determine the groups that potentially could receive more than one periodic vaccine booster.